NCT06510426View on ClinicalTrials.gov

Early Interferon-beta Treatment for West-Nile Virus Infection

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 14, 2024

Primary Completion Date

July 14, 2025

Study Completion Date

December 31, 2025

Conditions
West Nile VirusWest Nile Fever EncephalitisWest Nile Fever MyelitisWest Nile Fever With Other Complications
Interventions
DRUG

Rebif 44 MCG Per 0.5 ML Prefilled Syringe

Rebif 44mcg per 0.5ml administered subcutaneously

DRUG

Saline

0.5mL of saline administered subcutaneously

Trial Locations (1)

6423906

RECRUITING

Tel-Aviv Sourasky Medical Center, Tel Aviv

All Listed Sponsors
lead

Tel-Aviv Sourasky Medical Center

OTHER_GOV